Literature DB >> 23411108

Usefulness of sleep-disordered breathing to predict occurrence of appropriate and inappropriate implantable-cardioverter defibrillator therapy in patients with implantable cardioverter-defibrillator for primary prevention of sudden cardiac death.

Jens Kreuz1, Dirk Skowasch, Fritz Horlbeck, Carolin Atzinger, Jan W Schrickel, Henning Lorenzen, Georg Nickenig, Jörg O Schwab.   

Abstract

Advanced heart failure (HF) is associated with severe sleep-disordered breathing (SDB). In addition, most patients with HF are treated with an implantable cardioverter-defibrillator (ICD) for primary prevention of sudden cardiac death. The incidence of ICD therapy in such a patient cohort with SDB has never been investigated. The present study sought to determine the effect of SDB on the incidence of appropriate and inappropriate ICD therapy in patients with a categorical primary prevention ICD indication. A total of 133 consecutive ICD patients with New York Heart Association class II-III HF and depressed left ventricular function (≤35%) with no history of ventricular arrhythmia underwent a sleep study before ICD implantation and were followed for 24 ± 8 months, prospectively. A relevant SDB was defined as an apnea-hypopnea index of ≥10 events/hour. Of these 133 patients, 82 (62%) had SDB. Overweight (body mass index >29.1 vs 24.7 kg/m(2); p <0.001) was identified as the only independent risk factor for SDB. Appropriate ICD therapy intervention was significantly greater among patients with SDB than among patients without SDB (54% vs 34%, p = 0.03). Inappropriate ICD therapy intervention was documented more often in patients with SDB (n = 24 [29%] vs 7 [14%]; p = 0.04). An apnea-hypopnea index >10 events/hour was an independent predictor of appropriate ICD therapy on multivariate analysis (odds ratio 2.5, 95% confidence interval 1.8 to 4.04; p = 0.01). In conclusion, the present study is the first trial exploring the effect of SDB on the incidence of appropriate and inappropriate ICD therapy in patients with HF with a primary prevention indication. These results indicate that a preimplantation sleep study will identify patients with HF prone to receive appropriate and inappropriate ICD therapy.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2013        PMID: 23411108     DOI: 10.1016/j.amjcard.2013.01.277

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

Review 1.  Effect of Sleep-Disordered Breathing on Appropriate Implantable Cardioverter-Defibrillator Therapy in Patients With Heart Failure: A Systematic Review and Meta-Analysis.

Authors:  Younghoon Kwon; Ryan J Koene; Osung Kwon; Jessica V Kealhofer; Selcuk Adabag; Sue Duval
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-02

Review 2.  [Association of sleep-disordered breathing and malignant arrhythmias in patients with ischemic and dilated cardiomyopathy].

Authors:  Hazem Omran; Thomas Bitter; Henrik Fox; Dieter Horstkotte; Olaf Oldenburg
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2015-03-03

Review 3.  A systematic review of the association between obstructive sleep apnea and ventricular arrhythmias.

Authors:  Akhil Raghuram; Ryan Clay; Anusha Kumbam; Larisa G Tereshchenko; Akram Khan
Journal:  J Clin Sleep Med       Date:  2014-10-15       Impact factor: 4.062

Review 4.  Arrhythmia risk associated with sleep disordered breathing in chronic heart failure.

Authors:  Reena Mehra; Susan Redline
Journal:  Curr Heart Fail Rep       Date:  2014-03

5.  Sleep-disordered breathing and inappropriate defibrillator shocks in chronic heart failure.

Authors:  Thomas Bitter; Klaus-Jürgen Gutleben; Georg Nölker; Zisis Dimitriadis; Christian Prinz; Jürgen Vogt; Dieter Horstkotte; Olaf Oldenburg
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2014-07-29

Review 6.  Cardiac arrhythmias and sleep-disordered breathing in patients with heart failure.

Authors:  Wolfram Grimm; Ulrich Koehler
Journal:  Int J Mol Sci       Date:  2014-10-16       Impact factor: 5.923

7.  Primary Prevention Implantable Cardiac Defibrillators: A Townsville District Perspective.

Authors:  Nathan Engstrom; Geoffrey P Dobson; Kevin Ng; Hayley L Letson
Journal:  Front Cardiovasc Med       Date:  2020-10-27
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.